RAD21 and malignant colon neoplasm: The results showed that there were significantly negative expression correlations between the GSTM2 expression with the three transcription factors (Figures 4C–E), which suggested CTCF, RAD21, SP1 as potential transcription factors of GSTM2 in colon cancer.